Allspring Global Investments’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,265
Closed -$151K 2251
2024
Q3
$151K Sell
8,265
-1,493
-15% -$28.5K ﹤0.01% 1721
2024
Q2
$170K Buy
9,758
+788
+9% +$14K ﹤0.01% 1745
2024
Q1
$176K Buy
8,970
+756
+9% +$16K ﹤0.01% 1730
2023
Q4
$189K Buy
8,214
+1,928
+31% +$43.1K ﹤0.01% 1701
2023
Q3
$145K Buy
6,286
+396
+7% +$10.1K ﹤0.01% 1857
2023
Q2
$154K Buy
5,890
+5,311
+917% +$140K ﹤0.01% 1896
2023
Q1
$16K Sell
579
-258,812
-100% -$6.83M ﹤0.01% 2537
2022
Q4
$5.89M Buy
259,391
+53,571
+26% +$1.49M 0.01% 938
2022
Q3
$7.01M Sell
205,820
-56,050
-21% -$2.07M 0.01% 887
2022
Q2
$7.63M Sell
261,870
-107,038
-29% -$2.72M 0.01% 855
2022
Q1
$9.86M Buy
368,908
+31,963
+9% +$755K 0.01% 885
2021
Q4
$8.72M Buy
+336,945
New +$8.4M 0.01% 971

Other funds holding PRVA

Allspring Global Investments's PRVA Position: Q4 2024 in Review

Allspring Global Investments sold out of Privia Health (PRVA) in Q4 2024, closing a stake of 8,265 shares — an estimated $151K sold.

Allspring Global Investments first reported a position in PRVA in Q4 2021 and held it in 12 quarters. The position peaked at $9.86M in Q1 2022. 231 funds tracked by Wall St. Rank hold PRVA as of Q4 2024.

  • Allspring Global Investments reported no remaining Privia Health position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 8,265 Privia Health shares in Q4 2024, an estimated $151K.
  • Allspring Global Investments first reported a position in Privia Health in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Privia Health position peaked at $9.86M in Q1 2022.
  • 231 funds tracked by Wall St. Rank held Privia Health as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.